Importantly, our results revealed a surprising potential of IFN-γ and β-glucan in the conversion of MPE-Mφ from M2 (TAM) tendency toward anti-tumor phenotypes (M1), which could be helpful for improving anti-tumor immunity in advanced lung cancer patients. The gene discussed is IFNG; the disease is lung carcinoma.